Glycocholic Acid Sodium Salt
CAS No. 863-57-0
Glycocholic Acid Sodium Salt( Glycocholate sodium | Glycocholic acid sodium salt )
Catalog No. M19188 CAS No. 863-57-0
Glycocholic Acid Sodium Salt is a conjugated bile salt and ionic biologic detergent. It is involved in the emulsification of fats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 50MG | 33 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 60 | In Stock |
|
| 1G | 86 | In Stock |
|
Biological Information
-
Product NameGlycocholic Acid Sodium Salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlycocholic Acid Sodium Salt is a conjugated bile salt and ionic biologic detergent. It is involved in the emulsification of fats.
-
DescriptionGlycocholate sodium is a conjugated bile salt and ionic biologic detergent. It is involved in the emulsification of fats.
-
In VitroGlycocholic acid (GC) increases the cytotoxicity of epirubicin, significantly increases the intracellular accumulation of epirubicin in Caco-2 cells and the absorption of epirubicin in rat small intestine, and intensified epirubicin-induced apoptosis. Glycocholic acid and epirubicin significantly reduce mRNA expression levels of human intestinal MDR1, MDR-associated protein (MRP)1, and MRP2; downregulate the MDR1 promoter region; suppress the mRNA expression of Bcl-2; induce the mRNA expression of Bax; and significantly increase the Bax-to-Bcl-2 ratio and the mRNA levels of p53, caspase-9 and -3. A combination of anticancer drugs with Glycocholic acid can control MDR via a mechanism that involves modulating P-gp and MRPs as well as regulating apoptosis-related pathways.
-
In Vivo——
-
SynonymsGlycocholate sodium | Glycocholic acid sodium salt
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number863-57-0
-
Formula Weight487.61
-
Molecular FormulaC26H42NNaO6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (205.09 mM)
-
SMILES[Na+].[O-]C(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
-
Chemical NameSodium 2-[[(4R)-4-[(3R,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mohapatra M, Mishra A K. Effect of submicellar concentrations of conjugated and unconjugated bile salts on the lipid bilayer membrane.[J]. Langmuir, 2011, 27(22):13461-13467.
molnova catalog
related products
-
Monoethyl malonic ac...
Monoethyl malonic acid belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. Monoethyl malonic acid exists as a solid soluble (in water) and a weakly acidic compound (based on its pKa).
-
(RS)-MCPG
(RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.
-
RBN013209
RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
Cart
sales@molnova.com